| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.3M | — | +11.6% |
| R&D Expense | $3.5M | — | -12.3% |
| SG&A Expense | $8.3M | — | +14.5% |
| Operating Income | -$8.8M | — | +13.0% |
| Interest Expense | $493K | — | -16.4% |
| Income Tax | $0 | — | — |
| Net Income | -$9.4M | — | +13.9% |
| EPS (Basic) | -$0.07 | — | +30.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.2M | -26.5% | +216.2% |
| Accounts Receivable | $7.7M | -12.5% | +1.2% |
| Inventory | $2.9M | -4.3% | -30.0% |
| Current Assets | $25.7M | -16.3% | +28.9% |
| Total Assets | $78.5M | -8.1% | -1.6% |
| Current Liabilities | $29.5M | +1.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | +53.6% |
| Investing Cash Flow | -$278K | — | +17.5% |
| Financing Cash Flow | -$241K | — | -103.3% |
| +74.5% |
| Long-term Debt | $15.0M | +0.1% | -5.6% |
| Total Liabilities | $44.0M | +3.6% | -5.2% |
| Stockholders' Equity | $34.5M | -19.6% | +3.3% |